Mucormycosis is nearly 80 times more prevalent in India than in western countries, with 0.14 cases per 1000 people. Therefore, the clinician must have a high index of suspicion and identify the disease if it occurs in a patient with various risk factors. To discuss the latest guidelines for managing mucormycosis in the current pandemic for better patient outcomes, Docplexus has organized a webinar as part of CME, in collaboration with M.S.
Ramaiah University of Applied Sciences , discussing the topic “Mucormycosis - Epidemic within the Pandemic” on 31st July 2021, from 4:00 PM onwards.
